Pattern and Outcome of Eclampsia Managed at a General Hospital in North-West, Nigeria.
Keywords:
Eclampsia, Pregnancy and Hypertension, Maternal Mortality and Morbidity, NigeriaAbstract
Background: Hypertensive disorders of pregnancy constitute major threats to maternal health during pregnancy, labour and the post-partum period. Eclampsia is a leading cause of maternal morbidity and mortality especially in low income and middle-income countries.
Method: A retrospective review of the clinical records of women managed for eclampsia during a two-year period from December 2004 to November 2006 at the General hospital Aliero was undertaken.
Results: Fifty-eight patients were managed for eclampsia during the 2-year period of study. Eclampsia occurred before and during labour in 47 patients while 11 patients had post-partum eclampsia.
Conclusion: The reorientation of caregivers and the community in order to enhance awareness of eclampsia is recommended. The promotion of early presentation, routine antenatal care, and prompt referral to secondary center’s as well as the provision of the resources for adequate management of eclampsia is advocated.
References
Sibai B. Dekkar G, Kupferminc M. Pre-eclampsia. Lancet, 2005; 365: 785-799
ObiechiaN J A,UdigweG O. Pattern of Eclampsia in Onitsha, Nigeria. Orient J Med, 2004; 16(1): 16-20
American College of Obstetricians and Gynaecologists. Management of pre-eclampsia. Technical bulletin number 91. Washington DC. 1991
Themanagementofseverepre-eclampsia/eclampsia. Guideline no 10(A). March2006.Retrievedfrom
Onuh SO, Aisien AO. Maternal and foetal outcome in eclamptic patients in Benin City, Nigeria. J Obstet Gynaecol. 2004. 24(7): 765-8
Ekele BA, Bello SO, Adamu AN. Clusters of eclampsia in a Nigerian teaching hospital. Internat J Gynaecol Obstet. Jan 2007. 96 (1): 62-66
Mattar F, Sibai BM. Eclampsia: risk factors for maternal mortality. Am J Obstet Gynecol. 2000. 182 (2): 307-312
Sawhney H, Aggarwal N, Biswas R, Vasishta K, Gopalan S. Maternal mortality associated with eclampsia and severe pre-eclampsia of pregnancy. J Obstet Gynaecol Res. 2000. 26 (5): 351-357
Chukudebelu WO, Ozumba BC. Maternal mortality in Anambra State of Nigeria. Internal J Gynecol Obstet. 1998. 27 (3): 365-370
Moodley J. Maternal deaths associated with eclampsia in South Africa: lessons learnt from confidential enquiries into maternal deaths 2005-2006. S Afr Med J. 2010. November 9. 100 (1): 717-9
Abasiatai AM, Udoma EJ, Umoiyoho AJ. Presentation and Outcome of Eclampsia in Uyo, South-South Nigeria. Trop J Med Res, 2005; 9: 9-11
Ekabua JE, Itam IH. A review of pregnancy outcome in women with eclampsia at the University of Calabar Traching Hospital, Calabar. Trop J Obstet Gynaecol. 2000. 19: 66-68
Ozumba BC, Ibe AI. Eclampsia in Enugu, eastern Nigeria. Acta Obstet Gynecol Scand. 1993. 73 (3): 189-92
Abate M, Lekew Z. Eclampsia a five years retrospective review of 216 cases managed in two teaching hospitals in Addis Ababa. Ethiop Med J. 2006. 44 (1): 27-31
Mwinyoglee J, Amoko DHA, Simelela N, Marivate M. Eclampsia at Ga-Rankuwa hospital. South Afr Med J. 1996. 86 (12): 1536-1539
Katz VL, Farmer R, Kuller JA. Pre-eclampsia into eclampsia towards a new paradigm. Am J Obstet Gynecol. 2000. 182 (6): 1389-1396
Modukwenuy-RawdenC,BezuidenhoutMC. Factors influencing pre-eclampsia / eclampsia outcome in high-risk patients in Zimbabwe: research. Health SAGesondheid. 2003. 8(1): 39-56
Duley L, Handerson-Smart D. Magnesium Sulphate versus Phenytoin for Eclampsia (Cochrane Review) in the Cochrane Library. Chichester. UK. John Wiley and Sons Ltd, 2004; Issue 4: 4-5
Adewole IF, Oladokun A, Okewole AI,Omigbodum AO, Afolabi A, Ekele B, Audu LR, Obed IY. Magnesium sulphate for treatment of eclampsia: the Nigerian experience. Afr J Med Sci. 2000. Sept-Dec. 29 (3-4): 239-41
Khalid SK. Magnesium Sulphate and Other AnticonvulsantsforWomenwithPre-eclampsia,Reproductive HealthLibrary Commentary; 2003: No 9
Ana L, Villar J, Kim T, Kennedy S. Reducing Eclampsia Related Death: A Call to Action. The Lancet, 2008; 371: 705-706
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
